SCHEMBL22268216

SCHEMBL22268216

C/C=C1/CNCCN1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1583735 0.71 POLB (0.32) —
SCHEMBL27407554 0.71 — —
SCHEMBL12598830 0.71 — —
Hydrochloric Acid SCHEMBL5539110 0.69 SLC6A2 (0.32) —
SCHEMBL20936293 0.68 — —
SCHEMBL19902315 0.67 — —
Bromide SCHEMBL27475686 0.64 CA12 (0.31) —
SCHEMBL22268222 0.64 — —
SCHEMBL27537600 0.62 LMNA (0.35) —
SCHEMBL19449177 0.61 SIGMAR1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723733-B2 Hepatitis B antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2020-07-28 — — US disclosed
Send feedback